IBC/Clinica device conferences in 2004
This article was originally published in Clinica
Executive Summary
2004 will see an exciting new range of meetings offered by IBC informa as it works in conjunction with Clinica to bring you more conferences on the latest and most significant issues driving the industry at the same time as continuing its popular medical device courses. The following are already planned and Clinica will keep you updated with the latest meeting opportunities.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.